SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Graystone who wrote (4526)6/10/1998 11:23:00 PM
From: gringodoc  Read Replies (1) of 7041
 
nda delayed according to thestreet.com:

Schering-Plough (SGP:NYSE) says the new drug application for Zonagen's (ZONA:Nasdaq) impotence drug Vasomax will be delayed "about six to eight weeks," according to an investor who attended a presentation by the president of Schering-Plough Pharmaceuticals at the Goldman Sachs health care conference in California.

thestreet.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext